12:00 AM
 | 
Jan 13, 2014
 |  BC Week In Review  |  Company News  |  Deals

Advinus, Takeda deal

Advinus received a $3 million milestone payment from Takeda under a 2012 deal to discover compounds against predefined undisclosed targets for inflammation, CNS and metabolic diseases. Advinus said...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >